Dr Gurubasavaraj V Pujar
Vice Principal
| Department of Pharmaceutical Chemistry
JSS College of Pharmacy
(2021)
Karnataka
Expertise:
Pharmacology and Pharmacy
47
Publications
2
Projects
574
Scopus Citations
471
CrossRef
24 Years 7 Months Total Experience
Scopus
574
Citations
12
h-index
CrossRef
471
Citations
11
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
Best review article for the title “Bisphosphonates in bone metastasis-an overview”. Indian Journal of Pharmaceutical Education and Research, 2005, 39 (1); 14-20
2005
APTI
Received best Scientific poster presentation award in International Scientific Conference 2011, “Advancement in Health Sciences organized by Masterskill University College of Health Sciences, Cheras, Malaysia during 2-4th, November 2011
2011
Masterskill University College of Health Sciences, Cheras, Malaysia
Community & Membership
No Data Found
There is currently nothing to display here.
Indian Pharmaceutical Association
KAT/MYS/LM-052Association of Pharmacy Teachers of India
KA/LM-216Karnataka State Pharmacy Council
19265Personal Details
Doctor of Philosophy
2008
Bhoramdev College of Agriculture
Master of Pharmacy
1994
N/A
Bachelor of Pharmacy
1992
N/A
Vice Principal
Sep 2021 – —
JSS College of Pharmacy
| Department of Pharmaceutical Chemistry
Professor
Jan 2010 – Sep 2021
JSS College of Pharmacy
| Department of Pharmaceutical Chemistry
Assistant Professor
Jan 2005 – Jan 2010
JSS College of Pharmacy
| Department of Pharmaceutical Chemistry
Assistant Professor
Feb 1998 – Jan 2005
JSS Medical College, Mysore
Medical and Health Sciences
Scholarly Work
Design, Synthesis and Development of Novel DprE1 Enzyme Inhibitors as Anti-Tubercular Agents
OtherDesign and development of novel mycobacterial enoyl CoA reductase (InhA) inhibitors as anti TB agents
CompletedDesign and Development of Novel Mycobacterial EnoylCoA Reductase (InhA) Inhibitors as Anti-TB agents
Structure based design, Synthesis and Evaluation of Novel Antitubercular agents
Design, synthesis and evaluation of new chemical scaffolds as potential anti-cancer agents
Design, synthesis and evaluation of new triazoles as anti-tubercular agents
Design, Synthesis and Evaluation of Novel Azole Conjugates as Anti-Tubercular Agents
Inhibition of mortalin-p53 sequestration by novel synthetic compounds in breast cancer therapy
JSS College of Pharmacy
JSS AHER
Mysuru
-
Application No. :
202541051763
Filed :
25-05-2029
Published :
30-11--0001
Filed
Oxadiazole-pyrazole and Oxadiazole-Imidazopyridine conjugates as Novel DprE1 inhibitors for anti-tubercular therapy.
JSS College of Pharmacy
JSS AHER
Mysuru
-
Patent No. :
202441055448
Filed :
20-07-2024
Published :
26-07-2024
Published
Benzoxazole/ Benzothiazole linked 2, 3- substituted thiazolidine-4-ones as Novel LPA1 receptor inhibitors for breast cancer therapy
JSS College of Pharmacy
JSS AHER
Mysuru
-
Patent No. :
202341059308
Filed :
04-09-2023
Published :
30-08-2024
Published
Indole clubbed triazole derivatives as cell wall inhibitors for tuberculosis therapy
JSS College of Pharmacy
JSS AHER
Mysuru
-
Application No. :
202541001009
Filed :
25-01-2005
Published :
25-01-2010
Published
A compound for inhibiting DprE1 enzyme and synthesis thereof
Gurubasavaraj Veeranna Pujar
Arun Kumar Sethu
Dr Gurdyal S. Besra
Manisha Singh
-
Patent No. :
564218
Filed :
30-11--0001
Published :
30-11--0001
Granted
Scholarly Publications
Molecular Docking and Three‐Dimensional Quantitative Structure–Activity Relationships for Antitubercular Pyrimidine Derivatives
Dengue: The Ongoing Battle Between Humans and the Virus
Dual HDAC/PI3K inhibitors as a potential and emerging cancer therapy: a review
Developing pyrazole–oxadiazole conjugates as potent anti-tubercular agents: an in silico and in vitro approach
Piper betle extract inhibits ferroptosis by scavenging oxyradicals, hydroperoxides and inducing NRF2 regulated antioxidants
Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment
Novel hybrids of 1,2,3-triazole-benzoxazole: design, synthesis, and assessment of DprE1 enzyme inhibitors using fluorometric assay and computational analysis
Open AccessNovel β-L-1,3-thiazolidine pyrimidine nucleoside analogues: Design, synthesis, molecular docking, and anti-HIV activity
Showing 1 to 8 of 47 publications